-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 C5XdCyB/scSUufRi8f0y66XOSbLx1nwNW9rVTJS3h2hwg3oPfGi1xYl2Qw2+jqqI
 uqzbfxTTXSDEqLFw4xVKEg==

<SEC-DOCUMENT>0001193125-04-115039.txt : 20040707
<SEC-HEADER>0001193125-04-115039.hdr.sgml : 20040707
<ACCEPTANCE-DATETIME>20040707165314
ACCESSION NUMBER:		0001193125-04-115039
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20040706
ITEM INFORMATION:		
ITEM INFORMATION:		Financial statements and exhibits
FILED AS OF DATE:		20040707

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYO CELL INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000862692
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SERVICES, NEC [8900]
		IRS NUMBER:				223023093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23386
		FILM NUMBER:		04904627

	BUSINESS ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
		BUSINESS PHONE:		7277230333

	MAIL ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG. B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>FORM 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="3"><B>Pursuant to Section 13 or 15(d) of </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>the Securities Exchange Act of 1934 </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Date of Report (Date of earliest event reported): July 6, 2004
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>CRYO-CELL International, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact
name of registrant as specified in its charter) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>0-23386</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>22-3023093</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>3165 McMullen Booth Road, Bldg. B, Clearwater, FL</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>33761</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Registrant&#146;s
telephone number, including area code: (727) 450-8000 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="2"><B>Not applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item 7. Financial Statements and Exhibits. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><U>Exhibits<B></B></U> </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Press Release dated June 30, 2004 </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item 12. Results of Operations and Financial Condition. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">The information in this Item is furnished to, but not filed with, the Securities and Exchange Commission (the &#147;Commission&#148;) solely under Item 12
of Form 8-K, &#147;Results of Operations and Financial Condition.&#148; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2">On June 30, 2004, CRYO-CELL International, Inc. issued a press release that included financial information for the six months ended May 31, 2004. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated
herein by reference. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-2- </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">CRYO-CELL INTERNATIONAL, INC.</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">(Registrant)</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Date: July 6, 2004</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">/s/ Jill M. Taymans</FONT></P><HR WIDTH="83%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Name:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Jill M. Taymans</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Title:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Vice President, Finance</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-3- </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><U>EXHIBIT INDEX</U> </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>EXHIBIT<BR>NUMBER</B></FONT><BR><HR WIDTH="56" SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>EXHIBIT</B></FONT></P><HR WIDTH="53" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release dated June 30, 2004.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-4- </FONT></P>

</BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px">

<IMG SRC="g34118imag14.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="33%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2"><B>For Immediate Release</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2"><B>Contact:</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2"><B>Todd Atenhan</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">727-450-8000</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">727-723-0444 (Fax)</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2"><U>investor.relations@CRYO-CELL.com</U></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>CRYO-CELL
INTERNATIONAL, INC. REPORTS RESULTS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>FOR SECOND QUARTER 2004 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Company Reports Net Income, Increased Revenues, Higher Gross Margins, </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>and Strong Cash Position </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B><I>COMPANY IS ON TRACK WITH STRATEGIC PLAN TO ACHIEVE TRANSFORMATIONAL SUCCESS </I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Clearwater, FL &#150; June 30, 2004 </B>- CRYO-CELL International, Inc. (OTC Bulletin Board Symbol: CCEL) (the &#147;Company&#148;) today
announced consolidated revenues of approximately $3.2 million for the second quarter ended May 31, 2004, compared to approximately $1.6 million for the second quarter of fiscal 2003. The 96% revenue increase over the same 2003 period is primarily
attributable to an increase in recurring annual storage revenues and the effects of successfully implemented price increases during 2003 for newly enrolling clients. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Net income in the second quarter of 2004 was approximately $608,000, compared to a net loss of approximately $1.3 million in
the second quarter of 2003. The Company was profitable due to increased revenues and gross profits, coupled with a 5% decrease in marketing, general and administrative expense compared to 2003 levels. The decrease is primarily attributable to a
reduction in professional fees. The Company&#146;s gross margin increased to 77% of revenue in the second quarter of 2004 from 59% in the 2003 period. The gross margin improvement is a result of increased revenues as described above. In order to
maintain profitability, the Company must continue to control operating costs while increasing revenues and unit growth from its core business. Second quarter enrollments, a leading indicator of future revenues, increased 8% over first quarter 2004
levels. As of May 31, 2004, the Company had $3.4 million in available cash and cash equivalents and no long-term debt. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">For the six-month period ended May 31, 2004, the Company&#146;s revenues were approximately $5.8 million, compared to approximately $3.1 million for the
six-month period ended May 31, 2003. The 88% revenue increase over the same 2003 period is primarily attributable to an increase in recurring annual storage revenues and the effects of successfully implemented price increases during 2003 for newly
enrolling clients. Net income for the six-month period ended May 31, 2004 was approximately $823,000, compared to a net loss of approximately $2.2 million in the 2003 period. The Company was profitable due to increased revenues as described earlier.
The Company&#146;s gross margin increased to 76% of revenue in the first six months of 2004 from 58% in the 2003 period. The 18% gross margin improvement is a result of increased revenues as described above. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">The Company intends to continue its increased focus on its core business of
marketing its storage program for umbilical cord (U-Cord</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP><SUP>&reg;</SUP><SUP></SUP></SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">) blood stem cells, operational
expansion and strategic market development. During the second quarter 2004, the Company entered into a 10-year lease agreement to construct a customized, nearly 18,000 square foot good manufacturing practice (cGMP) facility in Oldsmar, Florida. This
highly secured, technologically advanced facility is designed to support the expansive and </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">growing base of CRYO-CELL clients. Located less than five miles from the Company&#146;s current building, the new
CRYO-CELL facility is expected to be completed by late summer 2004. The estimated capital investment in the newly constructed facility is over $1 million, of which $216,000 had been invested as of May 31, 2004. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">&#147;We are very pleased that CRYO-CELL has now reported net income in the
first two quarters of 2004, caused by continued increases in revenues and higher gross margins,&#148; said Mercedes Walton, CRYO-CELL&#146;s Chairman and interim Chief Executive Officer. &#147;We believe that CRYO-CELL&#146;s strategic plan to
achieve transformational success is well on track at a pivotal time of increasing public awareness and understanding of the significant benefits of umbilical cord blood stem cell preservation. We anticipate a continuing trend of solid performance
building on our recent revenue growth, increased earnings and enhanced shareholder value.&#148;<B></B> </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">About CRYO-CELL International, Inc. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Based in
Clearwater, Florida, CRYO-CELL is the world&#146;s largest U-Cord</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP><SUP>&reg;</SUP><SUP></SUP></SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> stem cell banking firm,
offering high-quality cord blood preservation exclusively for the benefit of newborn babies and possibly other members of their family. CRYO-CELL is accredited by the American Association of Blood Banks (AABB). </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">CRYO-CELL is a publicly traded company. OTC Bulletin Board Symbol CCEL. Expectant parents or
healthcare professionals may call 1-800-STOR-CELL (1-800-786-7235) or visit <U>www.CRYO-CELL.com</U>. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2"><B>Forward-Looking Statement </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Statements
wherein the terms &#147;believes&#148;, &#147;intends&#148;, &#147;projects&#148; or &#147;expects&#148; as used are intended to reflect &#147;forward-looking statements&#148; of the Company. The information contained herein is subject to various
risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements or paragraphs, many of which are outside the control of the Company. These uncertainties and
other factors include any adverse effect or limitations caused by any governmental regulations, proceedings or actions, foreign and domestic; any continued or increased losses, or any inability to obtain acceptable financing, where desirable in the
future, in connection with our operating or growth plans; any increased competition in our business; any decrease or slowdown in the number of people seeking to store umbilical cord blood stem cells or decrease in the number of people paying annual
storage fees; the effect of any future reduced cash position and future inability to access borrowings; any adverse impacts on our revenue or operating margins due to the costs associated with increased growth in our business, including the
possibility of unanticipated costs relating to the move into our new facility or the operation of the facility; any adverse developments impacting our continued relationship with and success of our licensees, foreign affiliates or investments in, or
relationships with, foreign companies; any inability to achieve increases in revenue or earnings from umbilical cord blood stem cell storage; any future inability to substantially achieve the objectives expected from the successful implementation of
our strategy; any decline in public market interest in the Company&#146;s business sector; any added requirements imposed on us by new laws or SEC regulations and costs thereof; any technological breakthrough or medical breakthrough that would
render the Company&#146;s business of stem cell preservation obsolete; any material failure or malfunction in our storage facilities; any natural disaster such as a tornado, other disaster (fire) or act of terrorism that adversely affects stored
specimens; the potential impact of negative market influences on the Company&#146;s portfolio of cash, cash equivalents and marketable securities; the costs associated with defending or prosecuting litigation matters and any material adverse result
from such matters; decreases in asset valuations; any continued negative effect from adverse publicity in the past year regarding the Company&#146;s business operations; any new technology rendering the Company&#146;s patented equipment or business
obsolete; any performance failures related to the Company&#146;s equipment or operations; any negative consequences resulting from deriving, shipping and storing specimens at a second location; any negative effect from the filed class action
shareholder lawsuits; and other risks and uncertainties. The foregoing list is not exhaustive, and the Company disclaims any obligations to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such
statements. Readers should carefully review the risk factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-KSB, Quarterly Reports on
Form 10-QSB and any Current Reports on Form 8-K filed by the Company. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">-END- </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-2- </FONT></P>

</BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g34118imag14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g34118imag14.jpg
M_]C_X``02D9)1@`!`@$`2`!(``#_X09^17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````4````<@$R``(````4````AH=I``0````!````G````,@```!(````
M`0```$@````!061O8F4@4&AO=&]S:&]P(#<N,``R,#`T.C`W.C`S(#`T.C$W
M.C$P``````.@`0`#`````?__``"@`@`$`````0```BZ@`P`$`````0```#8`
M````````!@$#``,````!``8```$:``4````!```!%@$;``4````!```!'@$H
M``,````!``(```(!``0````!```!)@("``0````!```%4`````````!(````
M`0```$@````!_]C_X``02D9)1@`!`@$`2`!(``#_[0`,061O8F5?0TT``O_N
M``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43
M$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-
M$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#/_``!$(``P`@`,!(@`"$0$#$0'_W0`$``C_Q`$_```!
M!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$`
M`@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R
M!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5
MXF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7
MI[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q
M0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*S
MA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_
MV@`,`P$``A$#$0`_`,F[H>'@?5,]2ONJLR>J58UV`QXBUA9;Z?4JZC.US-E^
M+[OYQ[/\%^B]1=M]1NH/QOJ52YNQOV:N^QK;#'J'U<JV&:_O,]/_`+<6#T[]
MO?L3I?K?L3[+]DO^Q?;OM'J_9MH^W^KZ/Z#^9V>O_(_X1;OU)^P?\T^F>OSM
MR]L;?H^OD;?Y[]-_Q'Y^]6\M\/K_`'_V,,.'B'#^Z[M'6\BRS8^NMC2VJS?N
MG:++'8CZGM_TU%[/TW^#_P`%_P`(I5=9OLNJH=4*M]E[#D.#O2(I)%7I.]K7
M69#1ZGI^I^C]&_\`G/T?J#M_9FZSZ<[=-OHQ.W(^C^;ZGT/YW_NBI7?LGT])
MVS;.ST_!^SZ7YO\`W"_ZRH/0R:LV=9L-E#7BMK;;K:B\N$%M3+[/7KA[OT>[
M'VN]7TE<Z;E_;<#'RCM#[JJ[+&-,AKGL;;L_Z:IU_LOU#NV>>_T8^G[/H^[Z
M/_@/_")8G[(V^_9.UG\_Z6Z8U^C_`(3_`$W_``B!X4BW625'_(G_`'5_\#2_
MR)_W5_\``TW1.J7(ZCB8UGI7/+7D-(`8]WTB6MU8UW[J`>O]*'-QX)GT[(]I
MV.U]/R_S/TG\VB-_9$>W[/'>-BE_DS_@/^@CZ?%&O@P?UGIE8W/R&@;=XT)W
M-]PFN!^E_FW_`,VD_K/3&;YNEU>_<P-<7_H]_J14UIL=_-.]/:S]-_@=_J5K
M*S]GVNW[']KV0W?]F^Q^C.F_T_MGZ;UMG^C_`+'Z1/7Z'IC[3]IV[_;O^RS]
M$;8_9OL]+Z?\_P#^DD:AW*/4ZC>L]+=9Z?VAH<7!@)D-+G':QK;'#TW;W?1V
MN3#K7336RPVEC+`2USV/9QOT=ZC&['?HK/8]9>3]CVG9]K_FCO\`1]*>:MO]
M(_PVW]S_`(;U/TWK).]'T#M^U>IZGMV_9=_T?^'_`$/H_P#&^SU$JAW*O4ZH
MZSTPAQ9>'EC2\M8'.=M$3MK8UUCOI?0:U)W5\!KFM+W2X-(/IV1[QOK]VS;[
MFK/_`%#U[/4];;[]T[?3^E;'I?G[]OI>EZ?YGH[/^U*J-]'>-OV^-HF/LNWZ
M?YV[_"?Z7;_@?^MI5#N4^I__V?_M"SA0:&]T;W-H;W`@,RXP`#A"24T$)0``
M````$``````````````````````X0DE-`^T``````!``2`````$``0!(````
M`0`!.$))300F```````.`````````````#^````X0DE-!`T```````0```!X
M.$))3009```````$````'CA"24T#\P``````"0```````````0`X0DE-!`H`
M``````$``#A"24TG$```````"@`!``````````$X0DE-`_4``````$@`+V9F
M``$`;&9F``8```````$`+V9F``$`H9F:``8```````$`,@````$`6@````8`
M``````$`-0````$`+0````8```````$X0DE-`_@``````'```/__________
M__________________\#Z`````#_____________________________`^@`
M````_____________________________P/H`````/__________________
M__________\#Z```.$))300````````"``$X0DE-!`(```````0`````.$))
M300(```````0`````0```D````)``````#A"24T$'@``````!``````X0DE-
M!!H``````TD````&```````````````V```"+@````H`50!N`'0`:0!T`&P`
M90!D`"T`,0````$``````````````````````````0`````````````"+@``
M`#8``````````````````````0`````````````````````````0`````0``
M`````&YU;&P````"````!F)O=6YD<T]B:F,````!````````4F-T,0````0`
M````5&]P(&QO;F<``````````$QE9G1L;VYG``````````!"=&]M;&]N9P``
M`#8`````4F=H=&QO;F<```(N````!G-L:6-E<U9L3',````!3V)J8P````$`
M``````5S;&EC90```!(````'<VQI8V5)1&QO;F<`````````!V=R;W5P241L
M;VYG``````````9O<FEG:6YE;G5M````#$53;&EC94]R:6=I;@````UA=71O
M1V5N97)A=&5D`````%1Y<&5E;G5M````"D53;&EC951Y<&4`````26UG(```
M``9B;W5N9'-/8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG````
M``````!,969T;&]N9P``````````0G1O;6QO;F<````V`````%)G:'1L;VYG
M```"+@````-U<FQ415A4`````0```````&YU;&Q415A4`````0```````$US
M9V5415A4`````0``````!F%L=%1A9U1%6%0````!```````.8V5L;%1E>'1)
M<TA434QB;V]L`0````AC96QL5&5X=%1%6%0````!```````):&]R>D%L:6=N
M96YU;0````]%4VQI8V5(;W)Z06QI9VX````'9&5F875L=`````EV97)T06QI
M9VYE;G5M````#T53;&EC959E<G1!;&EG;@````=D969A=6QT````"V)G0V]L
M;W)4>7!E96YU;0```!%%4VQI8V5"1T-O;&]R5'EP90````!.;VYE````"71O
M<$]U='-E=&QO;F<`````````"FQE9G1/=71S971L;VYG``````````QB;W1T
M;VU/=71S971L;VYG``````````MR:6=H=$]U='-E=&QO;F<``````#A"24T$
M$0```````0$`.$))3004```````$`````CA"24T$#``````%;`````$```"`
M````#````8```!(````%4``8``'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!
M9&]B95]#30`"_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1
M%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`#`"``P$B``(1`0,1`?_=
M``0`"/_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!
M`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A
M$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$
MDU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:V
MQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%1
M87$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4
MHQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G
M-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`R;NAX>!]4SU*^ZJS)ZI5C78#'B+6
M%EOI]2KJ,[7,V7XON_G'L_P7Z+U%VWU&Z@_&^I5+F[&_9J[[&ML,>H?5RK89
MK^\ST_\`MQ8/3OV]^Q.E^M^Q/LOV2_[%]N^T>K]FVC[?ZOH_H/YG9Z_\C_A%
MN_4G[!_S3Z9Z_.W+VQM^CZ^1M_GOTW_$?G[U;RWP^O\`?_8PPX>(</[KNT=;
MR++-CZZV-+:K-^Z=HLL=B/J>W_347L_3?X/_``7_``BE5UF^RZJAU0JWV7L.
M0X.](BDD5>D[VM=9D-'J>GZGZ/T;_P"<_1^H.W]F;K/ISMTV^C$[<CZ/YOJ?
M0_G?^Z*E=^R?3TG;-L[/3\'[/I?F_P#<+_K*@]#)JS9UFPV4->*VMMNMJ+RX
M06U,OL]>N'N_1[L?:[U?25SIN7]MP,?*.T/NJKLL8TR&N>QMNS_IJG7^R_4.
M[9Y[_1CZ?L^C[OH_^`_\(EB?LC;[]D[6?S_I;IC7Z/\`A/\`3?\`"('A2+=9
M)4?\B?\`=7_P-+_(G_=7_P`#3=$ZI<CJ.)C6>E<\M>0T@!CW?2):W5C7?NH!
MZ_TH<W'@F?3LCVG8[7T_+_,_2?S:(W]D1[?L\=XV*7^3/^`_Z"/I\4:^#!_6
M>F5C<_(:!MWC0G<WW":X'Z7^;?\`S:3^L],9OFZ75[]S`UQ?^CW^I%36FQW\
MT[T]K/TW^!W^I6LK/V?:[?L?VO9#=_V;['Z,Z;_3^V?IO6V?Z/\`L?I$]?H>
MF/M/VG;O]N_[+/T1MC]F^STOI_S_`/Z21J'<H]3J-ZSTMUGI_:&AQ<&`F0TN
M<=K&ML</3=O=]':Y,.M=--;+#:6,L!+7/8]G&_1WJ,;L=^BL]CUEY/V/:=GV
MO^:._P!'TIYJV_TC_#;?W/\`AO4_3>LD[T?0.W[5ZGJ>W;]EW_1_X?\`0^C_
M`,;[/42J'<J]3JCK/3"'%EX>6-+RU@<YVT1.VMC76.^E]!K4G=7P&N:TO=+@
MT@^G9'O&^OW;-ON:L_\`4/7L]3UMOOW3M]/Z5L>E^?OV^EZ7I_F>CL_[4JHW
MT=XV_;XVB8^R[?I_G;O\)_I=O^!_ZVE4.Y3ZG__9.$))300A``````!5````
M`0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`
M;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`#<`+@`P`````0`X0DE-!`8`
M``````<``0````$!`/_A$DAH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O
M`#P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53>DY4
M8WIK8SED)S\^"CP_861O8F4M>&%P+69I;'1E<G,@97-C/2)#4B(_/@H\>#IX
M87!M971A('AM;&YS.G@])V%D;V)E.FYS.FUE=&$O)R!X.GAA<'1K/2=835`@
M=&]O;&MI="`R+C@N,BTS,RP@9G)A;65W;W)K(#$N-2<^"CQR9&8Z4D1&('AM
M;&YS.G)D9CTG:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R<@>&UL;G,Z:5@])VAT='`Z+R]N<RYA9&]B92YC;VTO:5@O,2XP
M+R<^"@H@/')D9CI$97-C<FEP=&EO;B!A8F]U=#TG=75I9#IB935D931D-2UC
M8S<Y+3$Q9#@M83(T.2UB.6-C-S8V938P83(G"B`@>&UL;G,Z>&%P34T])VAT
M='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\G/@H@(#QX87!-33I$;V-U
M;65N=$E$/F%D;V)E.F1O8VED.G!H;W1O<VAO<#HR9#$V.#!F-BUC8S<Y+3$Q
M9#@M83(T.2UB.6-C-S8V938P83(\+WAA<$U-.D1O8W5M96YT240^"B`\+W)D
M9CI$97-C<FEP=&EO;CX*"CPO<F1F.E)$1CX*/"]X.GAA<&UE=&$^"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H\/WAP
M86-K970@96YD/2=W)S\^_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`-@(N`P$B``(1
M`0,1`?_=``0`(__$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`X9)3IHNR+!50QUMA!(8T
M22&@O=#1_):H+5<UV?\`F?\`6+]E_M7[&[[+MW]M^R-WJ^E_.>GM6,O9+J_K
M:WZN.HLMP=,<BS+_`$N[TMAW.]%M>WUMG\K^PO&U%BR&=W6ATX63+`1X:O4=
M5+V;_%M_XD<7^O;_`.?'KQE>S?XMO_$CB_U[?_/CTSFOD']Y?RWSGR>H269D
M_63HN-DNQ;,D.R&?SE537VN;_P`8W'9;Z?\`;4\3K_1LRBV_&RZ[*\<%UT2'
M,`[V5.'JL_S%4X95=&O)M6.[H)+('UL^K9F.H4F/I>[Z/;])_H_[:LY'7.CX
MV/5DWYE+,?(_F;BX;'?U;![$N"78_8KB'<-Y)5<'J?3^HL<_!R&9+&&'.K.X
M`G^4$+'ZYT?)R?LF/EU6Y.LTM=+Q'.YGYJ%'MLJQW;Z2H9O7>DX%OHY&0!>!
MN-+`ZRP#L754-L>S=_*3].ZUTKJF\8&2RYU?\Y7JU[?Z]-@9:S^TQ+AE5T:[
MUHJQM;>22202I)95GUIZ"RRRO[6+'4Z6FIC[6M/@^RAEC&_YR-7UWI%N"[J%
M676_%9`?:TR&DG;M>T>]COZR=P2_=.O@CB'<-])95?UI^KMHFOJ%#QWVO!CX
M_NHK>O\`178KLQN;2<9C_3=<'#:'1NV.=_50X9=BJQW#H)*G@]8Z5U%SFX&5
M5DE@EPJ<'0//:EG=7Z9TXM^WY5>-ZGT/5<&S'AN2HW5*L5=MQ)5\+J&#U"HW
M85[,BH':7UG<)^*L()4DDDDI22222E))))*4DDDDI22222E))))*4DDDDI22
M222E))))*4DDDDI22222E))))*4DDDDI22222E))))*4DDDDI22222E))))*
M4DDDDI22222E))))*4DDDDI22222G__0Q?J%_P"*[IW]=_\`Y[L72?XP?J.*
M1;UOI-<5`%^9C,'T?WLBEH_-_P!+7_;7.?4'_P`5N!_6?_U#U[:0""")!T(*
MM9LAAE!'[HL=VMAQQECH]RYV?_XG<C_PF_\`\]%>!KTKH'US^V=.ZCT/J+_U
MNNG(;B6G_"-#7[:7?\,QO_;J\U3^7@8<0/<+>8D)<)![J7H6#UC*Z9_BZPJL
M%VS,S\BS&I>-"W=8_>]O\K;[%YZNZ9AY%G^+SIO4<=I>[I>6_(>P?N"Q^YVG
M[GM3\H!X`?WA^168;N5?NE]%Z+T?$Z-T^O#QF@;0#;9'NL?'ONL=^<]Z0Z1C
MLZU^UZH9:^AV/>`/IRZNRNQQ_?J]-S/[:L8.;CY^'3FXS@^F]@>QP\#V/\IO
MYR5F917ETX;C^GO:]];0)]M>WU'._=_G&*C<K.]F^+]K=H4.PV>5^KV1AXOU
MC^M!RK*J:C=43ZA:T$;;#9])+ZF=-KR<;K3+*#^Q,[)><*FQL--9WA[ZF'Z-
M3OT7I?U%5P>AX/6NM?6O%RZFN+K*FU7%H+ZW%MGOJ?\`F[7;5K?4GJN1?B7=
M(ZB?\I=)>:+@>7,'MIN_E?N;O_)J?)M*MZAQ>`X="&,;B^\J^US.B]6'U2NR
MOJ[U5Q=30'7]+MC6ZMQTQF?O7>I[6?RU?S;[_J[]7L_KN2T.ZOEP^P\ACWQ3
MBXS?WJ<-KF_\9^D?_A$/ZX-;_P`XOJR[:-WVMPW1K$U&%=^O?3KNH_5C+JH!
M=;6&W-:-2?3.]X'_`%O<FD@F!.GN'U_22M0)@?H_+_BMGZK]-9@](H<_WY>4
MQM^9>[5]EM@]1[GO_.V[MC%D_7S`?C8K/K+TZ*>I=-<USK&Z>I4XACZKN/4;
M[O\`,]1;'U7ZE3U/H.%E5$&:FLL`_->P>G8W_.:J7U\R-GU>NPZQZF5U!S,;
M&I'TGO>YL[?ZK-R;$R]W7]ZCY=5TJ]LUVL>;L]-S69_3\?-K$,R:VV`>&X;H
M7.?7?J&59=T[ZNX5AIMZM9MON$@MI!`L#3_+G_H?RU:=1]9NE86#@=&QL;(I
MQ\=E=K[WN:=[1M=M#?S%B?64]6Q,KH7UDZI2RIV'>ZK-;02]C*WN_1V`_2]U
M?J?]<1QP'&#8._"+Z_HHF3P]>E_]T]K@8&)T[$KP\.L545#:QC?^J=^\]WYS
ME7P^CX^%U+-SJ/8,\5^K4!#=]>\&W_KC7^]7F/98QME;@]CP'-<TR"#JUS2A
M#,QW9KL$.G(96+G-\&.+F,)/\IS'J*SKOK\S)H\K]1;\##Q>K>K951'4;_I.
M:T[&[-OTC]%JV\6GI]O2LK,Q&_J_5&')+2``=]36?1'[[6;E@?4WI/2>H8W5
MG9F)1DN/4<AN^RMKG;3MT;8X;V\KHZ*<;`Z8WI-=N^S%Q(`/TC6UOI-L<W^R
MI<M<1HGBTM9COAC?9R/\6H`^J6*0()?;/G^D>B?XQ6M=]4<TN`.TUD3V/J,$
MA0_Q;?\`B1Q?Z]O_`)\>E_C`R*;/JMU*ECPZRGT1:P<MW65O9N_K-2'^Z/\`
MJG_=('\T/[O_`'+O=+`'3,0``#T*]!H/HM5I5>F?\FXG_$5_]0U&HR*,FL6T
M/;962YH>TR):36_7^2]NU12W/FOCL/)(DDD@E22222E))))*4DDDDI22222E
M))))*4DL3K74,W!ZITW;98S"R<AF/;#*W5EU@M%;'2?M3;'6MJ_25_H:O\)Z
MBHN^L/4J>EO<^+\RWJEG3:7M8&M:!8^IKQ4YX;NV5?HV67?S[Z_4M3QC)`(K
M5:9`/4I+F<7ZPY5W4.G&;6])SF-;CY%E+"ZZUU;[/3NNJN9]E?N;]#[%L?Z7
M\YZ:%?U[JN%]8,W#>?M.-DD4=,:6M&S*%5&1Z%KZV-=Z-GVO?ZEOJ;/11&*1
M-:;6KB&[U:2X_"^L^3=]6G'UK;>J,P3E790;2&U.<VU]&ZMPK:]NZG9^AQ[_
M`/A$.CZP];=9T_IM[RS-Q\[[)U6QK&#U);;=B^B+&>GLRJJO4]GI_P#32]F6
MNVAK^U'&-/%[1)<O_P`[:^H7=/9TWU:6W9&.V_U&U^ZK(JR[6!ONNVO:_#]Z
M'T[ZZU-Z32_,9=E9C,/[9DOJ8!6!MMM:U[_8UGJ>C[/8E[4ZV^B>./=ZQ)9.
M-UEO4^E9F1C-LQ;L8/K<';"YM@K9>',_GJGMVVU_2_[;6'T/ZV9=193UEUMU
MV93AVX%894++#D,(M<UU'I8S*G9#'^CZ[J[?3_G$!BD;[QZ=5&0%>-_@]DDN
M=K^O71;F,?2VZQC]C=X8`!9979D4X[M[VN]1[*'^_P#F/^&0,?ZVV.ZIA^O3
M;7A]1Q,6RNL"MWIVY5MM-;[;`]K_`$K-E?T?^N55I>U/M7FKCCW>I27'_6CK
MO5>G=7?3BY#JZC1C/K#F5.H99=?9CO=EO<S[2W'=55_@G_SBT[_KCTFC(LHL
M%H+'VTMLVM#'VT&IE]+'.>-KF.R*_?=Z5/\`PJ7M2H$:WV5QQU\'=27+Y7UN
MKRFX`Z5Z@-]^$;W.:R&TY5GI^C9O<7>I8UC_`.8;9L_TBN?6#J5S>GX>5TO)
M);?ET4[\?TK/4999Z-C*WWMLHW?N._TB7MRL`Z7W_:KB%$[T[B2Y3I?UR97A
M5T]4;;9U"K<W*=6U@:'MR*^G^G].MKK&OR<?U/2;Z/\`H_\`1J)^M%V+F"W+
MN=]BKLZD+V;6$QB/IJI97L8QW^$?^=_QB/M3LC^4J_=5QAZU)<GC_67/^WN%
M[;/2^W9=0IBH.%=.(S-KJ<YF]KG;]^QS;_\`C+%9K^N^`<=EEV-?58^NFWT_
MT9&V^JS*J+;W7,J^ACV-_2^C:]_^"2.*?07Y*XX]='HTESO6^JYYPNE9.!]H
MQ79^2RMU`;1ZQ8^JZUK?UKUJ*K/T5?\`A/\`C$*CZSY]7U9Z;U/['9U7)RG"
MJ]N.TLVNE]=C]FQWT'U^G]'TGV?GL0]N5`Z:GA5Q#7P>G26+GY^8_P"L.+T>
MNTX=%N-9DF]K6E]CV.%?V:GUVVU>QKO7M_1O]BSV?6C]G]3RL/,OLZBUK<>O
M$%%;2]]COM7V@_HMC-WZO[_=_P`56D,<B-.UTHR`_)ZI)<Y=]=L`4Y+\>BZZ
MS%%+GU':PD76C$VM]SW-LJM^G7:RM(?7?!^W#I[L+,9EEXK]%S:@[>X,?6UW
MZQ[?499O9_Q=O^B2]N?97%&KMZ-)<X?KQTUSMM%%UH]:NDN_1AL6MNN;:W]+
M_H\6[]'_`#BB/KQB6.QG4862^C)+OTKPVOV-KLR/6J]5[665[:7[]UE7II>U
M/LKCCW>E26#]9NHY=%72[.G7O#<S,JI=Z`J>;*K&6V?HG937T_X-GIOW*'0N
MH9[^J]1HS\EYIQ:<-U==[:JW,=D->^QMQH8S]+N8QGT_3WI<!X>*QY==^%/%
MK3T*2P>K]0ZC@]9P6A]C,'+>['_FZW5^J^MSL5OTQE^KZK'N>_\`1X_I_H_^
M&5"O/ZSD4Y^.<^_%SL#(-;*G58[K'_:!6>FUVV-9=C?G/=9Z+/H/_2?S/Z1#
M&2`;&O\`Z*@S`O0Z/6I+F<+KV6_J?V/)?8*J,C]GLN%=?Z;)95Z[[<L`A]55
MWN?0S&I9_-_S_P#@TW[:ZI_S1_:7JL^W?:?1]38-D?;?L7\S/T?0]OT_^N)'
M&1^'_.4)`_R[/__1QOJ#_P"*W`_K/_ZAZ]N7AOU)R<?&^M&#=D6-IJ:YP=8\
MPT2QS6RX_P`I>Q_M[HG_`)88W_;K/_)*QS,29B@=F#ER.#<;OAM5;+>M,KL&
MYC\D-<T]P;(<%T'UY^I5G0[CG8+2_I=ICN32X_X.P_Z-W^"L_P"M_P#&=>WH
M'U#'6OVQ]KI]3?ZPH]=GI"R=WJ;`?WO?Z?T%OY'5OJYE468^1F8MM-K2VRMU
MC""#V/N3Y9SQ1,0:_2%+1BC4A(BR="^"+USZC97V;ZEXA.+;F-LLN8ZNEK7F
M"^SZ;;'U^Q>??6KH>)TG/_4,JO+P;I=2ZM[7N9XU7;"[Z'YK_P#"+O/JH^VO
M_%O8^ASF7-JRC4YA(<'[K/3V;?=NWI^<B4('O(+<`(G(?U2DKPW85KW]%HZM
MTRNPES\9E5%M$GEU=&399Z3O^+1L*LXU]V;9B]7R>HWUFDY=C*I8PG=MQZ19
MZ%3=[=_\VM?JGVA_2<=N-D.Q\FQ]`JNDGW$M_G!/Z6M[=WJM>I](^T973;/M
M;;L>ZVRX6,<\[V>]S(ILGVU^W]`ZO\Q5SDN-D?U?ZS8X=:L]W`Z5@LZ5GVYV
M/1UI]F2[?E-L;0YMKO=#K!N'T?4_,1,S&QLGJ[.LUX'5L3-:P5O?CMJ:'M'Y
MMS7OLWK9^K[#]C=<^ZVQS[+&N%KW/@,LM;7M]4N<S]#Z:I_52^^RLC(N?;9Z
M<^]]CSI9:/TK;OT=3]GI;/3_`#$3/64JU%1*N'8?5S^J8C.J9U.;DX_6FOQ7
M;\5E3:&-K=+3N9[G._,_/6S5UNZNMK'=-ZC86@`O?75N='YSMEK&[O[*I]+R
M<S_G#>RU]HQ'/R&5%SGV,>]KJW>GML]F+]G9O]'9_2*[/^!1.INZBWJCSC/M
MLQGOQ:LBACG--8=9_2Z7-+7-;M_195;/\'^D2E1J)`T&BJK6SJY;L(X^59E=
M%Q^J])=>=U]55-#Z7._?^S7V/K8_^HK>$6T98S\K`ZGGYX:6MR+ZZO8T_2;C
MTUVLIHW?R&;UI?6+*SZL9M?3@3E-G((;`FNF+'UDN]OZ9VRK^HA]?N=;T,9V
M-;=48K?7Z;GL<0]]>[>VO:_^:<_V("5@"AZCP_UOJ4<(%ZG36OX!+^WK/_*K
M/_[;K_\`2Z'D=6;DTOQ\CHV;;3:-KZWU5EI![.:;T3K8?B]&BFZT.992!:'N
M-FTVU^I-@][_`-%O4^L/L;?A![WUX)>_[596YS2"&'T&V65;7LJ<_P#\$])-
M'#H>'OU_=7&^Y_!YZG%S,%OI=(_;&#BS+<8TX][&"9VT_:7OLK;_`&T?#J^Q
MUY)IQNL'-S-OVC.>REUQV?0:W>]U+&-W?FU+28_+?]5]V;=;CWN86^N);:T%
M^S'M]O\`A?3])S__``1'Z+;FEF6>HAS;ZKO3<XD^FX,KJ_3XS3]"F[=ZFQOY
MZ>9Z&P#1U_K?]\M$=M_!YWIW2JNF"T8%?7:1<=U@'H.#G_Z4A^[](BMQ[&LR
MXJZR<C.#&7Y+V8[K/38'M%%<GTZF?I7_`$&+6Z)U#,NS\FG+#@S(:W+P]T0*
MG?HO2]OT=FQEFQ_Z3]*IXW4:,?,Z@W)N?`O)8UVYP;6REEECF_2].IKFV_\`
M7$I3-D$`F@=$B(K0D//]-Z4>ETFC`'7:*22?3`QW-!/):U^[:ED=)9DX5N#;
M3UIU.3:;LLEE!?:_V;/4M+MS65>FS96SV+M7.8ZDO!]A;.X2-".5B4/R+/J?
M2^V^ZK(?CL]3(EWJM>[;O?N/OWL<D,I)NM;'FHQH5?3;1RJ<7*HQFXM+^OLI
M8W8P1CR&C0-;8?TC=O\`66ITW/;TW!IP<?I?4350T-:75UEQ[N>\^M]-[O<K
M717]1<W+&<QS<BNP5R2?3>6L;^GQVD_HZ;_I[/S'[T'H-P?7COR<B]W4'UEF
M7187;6VD^I9-4>E1Z>RQE&ST]]/^D0E*P;`-=E`55%+^WK/_`"JS_P#MNO\`
M]+I?MZS_`,JL_P#[;K_]+K624?%']W\5U'N7)_;UG_E5G_\`;=?_`*72_;UG
M_E5G_P#;=?\`Z76LDEQ1_=_%5'N7)_;UG_E5G_\`;=?_`*72_;UG_E5G_P#;
M=?\`Z76LDEQ1_=_%5'N7)_;UG_E5G_\`;=?_`*72_;UG_E5G_P#;=?\`Z76L
MDEQ1_=_%5'N7)_;UG_E5G_\`;=?_`*72_;UG_E5G_P#;=?\`Z76LDEQ1_=_%
M5'N7)_;UG_E5G_\`;=?_`*72_;UG_E5G_P#;=?\`Z76LDEQ1_=_%5'N7`=F8
M[\P9K^C]0=>V"TN:"T%H<QKV4NR?199L>]OJMK]1)N5@LH?CL^K^0VBQVZRH
M8U(8YTSN?7ZNUSEOI(\8[?B4</C^3@-S,=M[,@=&S]]0VT@L:65C;Z7ZO2[(
M]&C]'[/T-;$XS,-KWV#H&2'VN]2QPQZ9<\M=7ZCW>K[G^G997O\`W+%O))<8
M[?B5</C^3S9/2',:P_5JTL8TL8TXM$!I.YS&CU/:USD5V5@NV;OJ_D'TG!]<
MX])VN:`QCV?I?:]C&M:URWTDN,=O^<5</C^3S;#TAAEGU:M:=P?(Q:![A,/_
M`)SZ7O<I>ITO:UO_`#;NVL8:V#[+1`8Z=];?TGMK?N][%T22/N>!_P`8JX?'
M\`X%67@T5VUT_5_)JKOTN8S'I:'P-OZ5K;?TG]M19=TUE3J6?5R]M3]N^L8U
M`:=FM>YGJ;7>G^8K7UJ`;T+-R?7LQWXV/=92^NUU/Z3TW-IW.J=6Y_Z0_HZ_
M](N3N^L]M71<W#QG7MN^SLM.9=E3:'FFEV_&KM<[(^S6/'TZ[/YZU/A'CU`Z
MZZK9$1WZ>#THS,,6,M'0,D6UM%=;QCT[FL`+16QWJ[FLVNV[$&>D$-!^K5L,
M`:P?9:-`"7M:W])^:]VY5,CZ\WE[VXV)54VK*90]^3<&PUUHQW.NJK#K<7=N
M]1ES_5KV?Z1!;]<;6=9QK[Z_2QLO'QV68]E\"I]F3D8WVJL.9LN9Z;*K=_Z#
M]6_2HB$M^'_G(,H]_P`/['7LS<.VU]UO0,FRVUGI66.QZ2YS/]$][K=SZ_Y"
MAZ_38>/^;M\6-#'_`*M1[FC;M8_]+[F-].OV_P`A4G?7JQ^QM.&VMS[J*]UU
MD-8+;[,1]65MK_5LMOH^KZ/Z7]#^F_P?IOL]*^N3>I9>%C,Q/3&72VYSS:WV
MEWJ;F4L+6ORO2=5^F<S^;0,9`?+5?UD\4;^;\&6_I4,'_-NZ*A%?ZK1[1.^&
M?I/9[_>G;=@#$KPG=`R[<>IQ>RNVFJP!Q)L=9^EN?^D<][G[T+/;=GY/4&NR
M<FFVF]F%@T47/I;N?33D?:;?0<Q]NSUKKG>[^CTH=K\<_6/'Z3C]5O!KHLJS
M*W9#G/?OKVX[*F>[;DT[+,JW+_G6?GV_N+0CZ<6\E=:OPZ-E]O3+&5UV?5R]
M[*I])KL6@ALG>[TVFSV;GC>G;=TUIW-^KMX/OU&-0#^E&V__``O^&;_._P"D
M0J&V8%%&?CY&1:S,S::Z:LBZRX''L<,:?T[W_P`XUSL__MM6LW!KLZPVT9F5
M3Z3?M.41D/;2QC6^E17]GW#&:VRQC[W;Z_\`M/=ZO\ZAIXUKU._572_+]U`Q
MW26&6?5JYI$@$8M`Y;Z;N+/SJ_T?]14>I8>+E-H&%T?*P#2\/=Z..QF\!EE+
M&/?AY>%D-]/UG^GLR%7&<<OI76K>F]2??3676XK'9-C;:V,JLWV?:8LN=ZM]
M3[Z<-S]C*_3];]'^B6AU3JV9;TG!M-.5T_'LR,5N9D6.:QXHL!=<_P!7&L=;
M1^D;57=8]F/_`#J<!1'G6I_[E6A!_L3-OQWX>-BYW1LWJ!Q6-:VW)HJL<7-&
MPV_I+G?I'JW7UGT:VU5='SJZV"&L;56&@#LUK;EA].SNLL_8&;G/L<<F<?*K
M%IW2^I[Z;+\+9Z#6555_:[KW?K'Z3_0_HU&Z_J0P^O8PNM;;B%M]5GVQ^T-=
MC>M^KY/IBY]E;F^O9C_HL;]+7_@/8EP`FC7V_P!;A4):7KKY=G;R>ITY;0S*
MZ)EWL:9:VVBIX!\0'W.0'6=+>US7_5RYS7[=P.+00=@+:MWZ3_!M=^C_`'$?
M(ZAU[T>D6=-PA?5E[#G^NX-LJ8YK':PZO]+[K-_L?_-_S7O5#J]V0[ZW58M5
MMAJ^P^K90S)LH`+;V;KV5U'9;<S']3]#9_.L30!M5:$Z2_=2>^O3IW3EW27.
M<X_5JXNLC>3BT2Z#N;N_2>[:Y6/VI5Z@M_8F9ZC2'!_HU2'!KJFNW>M])M3W
MU_\`%K-H^OU-^)5DMIH8+<L8A;;DED!S:[&9/]'<_P!+]+LMW,K]%:?6;#;G
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M=M3WY&9Z>_WU^KZMZ`HBZ/7K)1WJ^W[K:NOQ+[GWW=&ZB^RP$&1H-S/0<^IG
MVK939Z/Z/U:=EBE3E8M!8:^C=0W5V&X/<T.<;"TT>I98_)<^Y_HN]/\`2[_8
MJO2NI]5;TGJ&/7C9-V5BV9C*<ESQ=5OK]1^/6RVY[<R]F_90S]#:_?\`SBQ:
M^N]9HZ59:QUF5@MNPOUJVP$ESF8SLW%WW6U6NWY5C_H>RG]/19Z=7T'"%V--
M#7S*)JM]?`/3G/Q3DG+/0<HY)$&\T4^H1&R/5]7?]#V*+<O!;C.Q&_5_);C/
M=O?0,>D5ETA^]U7J['/WM:Y4\CKG5V?6*[&9B[B<.QV'2ZRH:M?4&Y%GZTUF
MRSWV6?X?T:Z_2_[4(+.MY;_J-9G@QDUW^D;-P))^UMI];VW.:U^U^_999Z'J
M?X/[&FD5&R!6GZ7?9(-G<]>C_]+ADEAI+5<UW$EAI)*=Q>S?XMO_`!(XO]>W
M_P`^/7SZDJ_-?(/[S/RWSGR?JI)?*J2I-M^JDE\JI)*?JI)?*J22GZJ27RJD
MDI^JDE\JI)*?JI)?*J22GZJ3.V[3OC;'NGB/-?*R22GZI$1IPG7RJDDI^JDE
M\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)
M*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^E^O485U&,W,
MR+,9HRZ#0^H`DWAX^RL.^J]NUUVW\U::^54DX_*/JCJ7ZJ27RJDFI?I[_)G[
M1,^G]OVMY^G$6^G'\OT_M'_">EZG^#5JST_3=ZL>G!W[HV[8]V[=^:OE=)$[
MC?H@/U#;]@]7%]3;OD_9)^CNV'^:_P`'ZGH>IL_/]+U?3_PB*ST/4LV;?5T]
M7;&Z8]GJ1[OH_1W+Y922^W93]/YW[*W4?M#T-V_]6]?9.^/\!ZO^$_XM6U\J
MI)'8;I?IW_(WVR_^C?;-GZS]#U=D#^?_`,)Z>S9_.(+?^;7H8VW[#]GWG[)'
MI;-\:_9OS/4_XI?-"2=_C(^SJ_522^54DQ+]5*GU#]F?HOVAZ<;G>EZO$['^
MKS^9Z/J>IO\`T:^84D1OU^B"_52J9'[-]`^MZ?H>LW?^[ZN]NSU=GY_K[/YS
M\]?,"20^N_11VZ?5^IG>AZK-^WU?=Z4QNC_";/SOZZCF?8_LMGV[T_LNW]-Z
MVWT]O_">I^CV_P!9?+:27;=+]2XWV;T&?9=GH1^C]*-D?R-GLVHJ^54D"I^J
(DE\JI)*?_]D_
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
